secwatch.observer — SEC 8-K summary
======================================

Issuer:     908 Devices Inc. (MASS)
CIK:        0001555279
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001104659-25-059685
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Board changes: Eisenberg resigns, co-founder Brown appointed director
---------------------------------------------------------------------

- Marcia Eisenberg resigned from board and compensation committee effective June 12, 2025.
- Eisenberg's resignation follows the company's sale of its bioprocessing product portfolio.
- Co-founder Christopher D. Brown appointed to board as Class III director term expiring at 2026 annual meeting.
- Brown is currently VP Analytics R&D at Repligen (RGEN), which purchased 908's bioprocessing portfolio.
- Brown waived initial compensation under the non-employee director policy; continues consulting agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1555279/000110465925059685/0001104659-25-059685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1555279/000110465925059685/tm2517904d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-059685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer